Differential uptake of recent Papanicolaou testing by HPV vaccination status among young women in the United States, 2008–2013

Sauer, Ann Goding; Jemal, Ahmedin; Fedewa, Stacey A.

doi:10.1016/j.canep.2015.05.002

Cited by 33 publications

(31 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, our survey results were consistent with those from a previous national study (Sauer et al, 2015). There may also be a selection bias, with greater participation of with pro-health attitudes.…”

Section: Discussionsupporting

confidence: 92%

“…Moreover, when the relationship is examined controlling for age and race of the respondent, we found that women who had been vaccinated had a three times greater odds of having been screened for cervical cancer within the last three years. This is consistent with recent research that used a national sample and found uptake of Pap testing was lower among those who had not initiated the HPV vaccination series (Sauer et al, 2015). It is also consistent with other health behavior literature that has demonstrated that pro-health behaviors cluster and a person who makes the decision to engage in one protective health behavior (e.g.…”

Section: Discussionsupporting

confidence: 92%

“…Some studies have found that Pap screening was either positively associated with vaccination or no association was found (Williams et al, 2013, Anhang Price et al, 2011, Caskey et al, 2009). Using a national dataset, one of these studies found that a lower percentage of women who were not vaccinated reported having a recent Pap test as compared to vaccinated women (81.0% vs. 90.5%) (Sauer et al, 2015). The findings of the limited research to date suggest that HPV vaccination may not have a negative effect on women's participation in cervical cancer screening.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Differences in cervical cancer screening knowledge, practices, and beliefs: An examination of survey responses

Kasting

Wilson

Zollinger

et al. 2017

Preventive Medicine Reports

View full text Add to dashboard Cite

Among the identified barriers to HPV vaccination is the concern that women may compensate for their reduced susceptibility to cervical cancers by reducing cervical cancer screening. This exploratory study examined the relationship between cervical cancer screening rates and HPV vaccination. We conducted a cross-sectional survey using a convenience sample of women aged 21–35 attending a local minority health fair in July 2015. Data were analyzed in 2015–2016. Outcomes assessed were: receiving a Pap test within the last three years, awareness and comfort with current Pap test recommendations, and knowledge regarding the purpose of a Pap test. A total of 291 women were included in the analyses. Mean age was 28.5 years and 62% were non-Hispanic black. 84% had received a Pap test in the last three years and 33% had received at least one HPV vaccine. Logistic regression results showed that women who had been vaccinated did not have lower odds of having a Pap test in the past three years (OR = 1.32; 95% CI = 0.66–2.65). In an adjusted regression model controlling for age and race, vaccinated women were significantly more likely to have had a Pap test (AOR = 3.06; 95% CI = 1.37–6.83). Yet only 26% of women knew the purpose of a Pap test and the proportion who answered correctly was higher among non-Hispanic white women. Women who have been vaccinated for HPV are more likely to have been screened for cervical cancer. These results suggest areas for more robust studies examining pro-health attitudes, behaviors, and communication regarding vaccination and preventive screening.

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Discussionsupporting

confidence: 92%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Differences in cervical cancer screening knowledge, practices, and beliefs: An examination of survey responses

Kasting

Wilson

Zollinger

et al. 2017

Preventive Medicine Reports

View full text Add to dashboard Cite

show abstract

“…Recent literature has indicated that young women who initiated HPV vaccination were more likely than unvaccinated women to report having a Pap test in the previous 3 years [8]. Although the effect of vaccination on compliance with Pap testing guidelines has been examined, there is little information about how the number of vaccine doses affects subsequent cervical cancer screening behavior.…”

Section: Introductionmentioning

confidence: 99%

Effect of number of human papillomavirus vaccine doses on guideline adherent cervical cytology screening among 19–26 year old females

Hirth

Lin

Kuo

et al. 2016

Preventive Medicine

View full text Add to dashboard Cite

Purpose Little is known about how the number of HPV vaccine doses affect adherence to screening guidelines. This study compared adherence to cervical cancer screening by the number of HPV vaccine doses received by young women and assessed whether the specialty of vaccinating providers affected behavior. Methods This retrospective cohort study using administrative insurance claims records included 24,964 19–26 year old women who received at least 1 injection of the HPV vaccine between January 2006 and November 2009. Vaccinated young women continuously enrolled in a nationally-representative private insurance plan for 6 months prior to and 37 months after HPV vaccine administration were included. Logistic regression was used to compare the odds of Papanicolaou (Pap) testing 3 years after vaccine initiation by number of vaccine doses and provider type. Results In this sample, 79.3% had a Pap test 3 years following vaccine initiation. Receiving 1 (aOR: 0.60, 95% CI 0.55–0.65) or 2 (aOR: 0.80, 95% CI 0.74–0.87) doses was associated with decreased odds of Pap testing compared to 3 doses. Many young women in our sample (16.5%) were diagnosed with cervical dysplasia prior to HPV vaccination. Patients vaccinated by non-obstetrician/gynecologists were less likely to get a Pap test following vaccination. Conclusions Women who received 1 or 2 doses of the HPV vaccine were less likely that those who received 3 doses to be screened for cervical cancer 3 years following vaccine initiation. Pediatricians and primary care physicians should convey the importance of initiating and continuing screening to HPV vaccinated patients.

show abstract

“…51,52 The changing landscape of cervical cancer screening will likely present challenges in terms of equal access to the increasing number of possible screening approaches. 53,54 Therefore, it is necessary that we continue to monitor rates of cervical cancer screening and the impact of screening on cancer rates in the current and future eras, especially for at risk populations such as minorities and women of lower socioeconomic status.…”

Section: Discussionmentioning

confidence: 99%

Impact of Widespread Cervical Cancer Screening

Yang

Soulos

Davis

et al. 2018

American Journal of Clinical Oncology

View full text Add to dashboard Cite

Objectives With recent approval of standalone HPV testing and increasing uptake of HPV vaccination, some have postulated that we are moving towards a “post-Pap” era of cervical cancer prevention. However, the total number cases that have been prevented by Pap smear screening as well as its impact on racial disparities are unknown. Methods We estimated national cervical cancer incidence from 1976 to 2009 using the Surveillance, Epidemiology, and End Result (SEER) database. Screening data were obtained from literature and National Cancer Institute Progress Reports. We examined early, late, and race-specific trends in cancer incidence, and calculated the estimated number of cancers prevented over the past three decades. Results From 1976 to 2009, there was a significant decrease in the incidence of early-stage cervical cancer, from 9.8 to 4.9 cases per 100,000 women (p < .001). Late-stage disease incidence also decreased, from 5.3 to 3.7 cases per 100,000 women (p < .001). The incidence among black women decreased from 26.9 to 9.7 cases per 100,000 women (p < .001), a greater decline compared to that of white women and women of other races. After adjusting for “pre-screening era” rates of cervical cancer, we estimate that Pap smears were associated with a reduction of between 105,000 to 492,000 cases of cervical cancer over the past three decades in the U.S. Conclusions A large number of early and late-stage cervical cancers were prevented and racial disparity in cancer rates were reduced during an era of widespread Pap smear screening.

show abstract

Differential uptake of recent Papanicolaou testing by HPV vaccination status among young women in the United States, 2008–2013

Cited by 33 publications

References 34 publications

Differences in cervical cancer screening knowledge, practices, and beliefs: An examination of survey responses

Differences in cervical cancer screening knowledge, practices, and beliefs: An examination of survey responses

Effect of number of human papillomavirus vaccine doses on guideline adherent cervical cytology screening among 19–26 year old females

Impact of Widespread Cervical Cancer Screening

Contact Info

Product

Resources

About